Palvella Therapeutics, Inc. · NASDAQ:PVLA
Jenkins George M sold 27,500 Palvella Therapeutics, Inc. shares (Form 4)
Traded Sep 11 to Sep 15, 2026 · Filed Sep 15, 2026
From Sep 11 to Sep 15, 2026, Jenkins George M (Director) sold 27,500 Palvella Therapeutics, Inc. shares at an average US$151.53 for US$4.17M under a trading plan, leaving 160,116 shares. Filed Sep 15, 2026 (Form 4).
- Sold
- 27,500 shares
- Price
- US$151.53 average (US$149.38 to US$153.10)
- Value
- US$4.17M
- Holding after
- 160,116 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | Sale | 6,520 | US$150.62 | 181,096 | Direct |
| Sep 11, 2026 | Common Stock | Sale | 4,577 | US$151.72 | 176,519 | Direct |
| Sep 11, 2026 | Common Stock | Sale | 1,274 | US$153.06 | 175,245 | Direct |
| Sep 14, 2026 | Common Stock | Sale | 5,632 | US$151.46 | 169,613 | Direct |
| Sep 14, 2026 | Common Stock | Sale | 6,160 | US$152.12 | 163,453 | Direct |
| Sep 14, 2026 | Common Stock | Sale | 1,560 | US$153.10 | 161,893 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 954 | US$149.38 | 160,939 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 263 | US$150.40 | 160,676 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 560 | US$151.33 | 160,116 | Direct |
Source
Related
- Palvella Therapeutics, Inc.
- Jenkins George M
- Palvella Therapeutics, Inc. shareholders
- Form 4 · Jenkins George M · Oct 14, 2026
- Form 4 · Jenkins George M · Apr 1, 2026
- Form 4 · Goin Kathleen · Sep 18, 2026
- Form 4 · Kiritsy Christopher P · Sep 4, 2026
- Form 4 · Goin Kathleen · Aug 20, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Aug 14, 2026